Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection
Received 4 July 2012
Accepted for publication 9 August 2012
Published 1 October 2012 Volume 2012:6 Pages 1585—1593
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Akito Odaka,1 Hiroshi Toshida,2 Toshihiko Ohta,2 Nobuhito Tabuchi,3,4 Daisuke Koike,4 Chikako Suto,3 Akira Murakami3
1Human and Environmental Safety Evaluation Center, Lion Corporation, Kanagawa, Japan; 2Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka, Japan; 3Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan; 4Pharmaceutical Research Laboratories No 1, Research and Development Headquarters, Lion Corporation, Kanagawa, Japan
Purpose: We examined the efficacy of retinol palmitate (VApal) for dry eyes using dry eye model rabbits whose lacrimal glands were resected.
Materials and methods: After alkaline injury on keratoconjunctival epithelium, VApal eye drops were administered 6 times a day for 7 days. The efficacy of VApal was also compared with that of 0.1% hyaluronic acid eye drops.
Results: The fluorescein staining and rose bengal scores showed a significant decrease compared with the score in the vehicle group at 7 days (P < 0.05) in the 1000 IU/mL VApal group and at both 3 days (P < 0.05) and 7 days (P < 0.01) in the 1500 IU/mL VApal group. Histological examination revealed recovery of the corneal epithelium, and PAS staining disclosed the recovery of mucin-producing lower palpebral conjunctival goblet cells after 7 days in the 1500 IU/mL VApal group compared with the vehicle group. Results from impression cytology showed a significant increase in density of conjunctival goblet cells compared with that in the vehicle group after 7 days in the 1000 IU/mL VApal group and after 3 and 7 days in the 1500 IU/mL VApal group. There were no significant changes in tear flow in either group. Topical application of VApal at 1500 IU/mL showed greater improvement than 0.1% hyaluronic acid in both fluorescein and rose bengal score and in the density of conjunctival goblet cells.
Conclusion: It is suggested that VApal is effective for the improvement of keratoconjunctival epithelial damage associated with tear abnormalities, such as dry eyes.
Keywords: cornea, dry eye, hyaluronic acid, vitamin A, wound healing, retinol palmitate
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]